Today’s blog is written by Chuck York, VP of Manufacturing Operations at Promega.
Coronavirus SARS-2-CoV continues to fuel unprecedented demand for COVID-19 related products. Once a term relegated to virology research labs, “coronavirus” is now a household term and a global crisis that has upended lives, disrupted entire economies and shaken our sense of normalcy.
Clinicians, researchers, government officials and the general public are understandably concerned about the availability of reagents for coronavirus testing. At Promega, we are hearing the needs and concerns of our scientific colleagues and partners, and we are doing all that we can to help alleviate them.
At Promega, we are hearing the needs and concerns of our scientific colleagues and partners, and we are doing all that we can to help alleviate them.
As a global company with thousands of products, we have been meeting customer demand in response to market dynamics for decades. Our long-term approach has served customers well. Our efforts to provide support for the COVID-19 response began in early January, with our work with our colleagues and customers in China. We are applying what we’ve learned to propel us forward in the most efficient way now.
We continue to increase production of all COVID-19 related reagents and instruments due to an unprecedented increase in global demand. Production lines that were running one shift 5 days a week are now operating 3 shifts seven days a week, and we continue to take measures to increase our manufacturing capacity.
Today’s article is written by guest blogger Vince Debes, this year’s winner of the Promega Art Contest for Creative Scientists. He will be starting a Master of Science program in Geological Sciences in the School of Earth and Space Explorationat Arizona State University this fall.
It’s incredible how seemingly insignificant actions can lead to major events years down the road. When my partner and I were testing out our new camera shutter remotes in the Grand Tetons on the way to do field work in Yellowstone, I never imagined an image we captured would lead to a grand prize in the Promega Art Contest for Creative Scientists. The four-minute-long exposure was taken at midnight with a full moon and shows the ghostly, almost imperceptible, movements of Colter Bay marina vessels against a backdrop of trailing stars and the stolid Tetons.
The Virology lab at the Universidade Federal da Bahia (UFBA), led by Dr. Gúbio Soares, has developed a fast and specific real-time PCR assay using GoTaq 1-Step RT-qPCR for detection of SARS-2-CoV (the coronavirus previously named 2019-nCoV), which causes the respiratory disease COVID-19. The Maxwell RSC instrument is used for automated extraction of RNA from oral-pharyngeal secretion collected by swab or bronchial wash prior to the assay. This coronavirus-specific assay can shorten the time to identify SARS-2-CoV from 48 hours to 3 hours (1), providing critical information to public health officials in a timely fashion.
“Promega has been providing all our reagents for standard and real-time PCR and also for nucleic acid extraction. It’s a company I can rely on the relationship; they are our partners and have provided excellent support both technically and financially. Promega is the base of all our assays.” Dr. Gúbio Soares.
Dr. Soares’ laboratory has experience developing assays to identify and detect emerging viral pathogens. Their laboratory first identified the Zika virus as the etiologic agent in the large outbreaks of acute exanthematous illness (AEI) in northeast Brazil in April 2015 (2). Zika was eventually declared a public health emergency of international importance by the World Health Organization in February 2016, after increased incidence of microcephaly was detected in the infants of women infected during pregnancy. Many of the lessons learned in the management of the Zika crisis are informing how scientists are addressing SARS-2-CoV. The Zika response was characterized by a collaborative spirit to share data, samples and resources among scientific labs across the globe.
In times of rapid growth, we look to the future with excitement while also assuring that our expansion is sustainable. The Promega Global Facilities Planning Team emphasizes environmental stewardship and long-term planning. Each building is designed to meet ambitious sustainability goals, and innovations incorporated into each project inform the next. In 2019, we finished construction on two new buildings in Europe and made progress on two important facilities at our headquarters in Wisconsin.
As Promega grows globally and locally here at headquarters, the construction of new and expanding facilities are considered with great care to ensure a commitment to sustainability. Between April and November of 2019, the parking ramp located near the Feynman Center received a massive upgrade with long-term impacts on the company’s sustainability goals.
Last year, on Promega’s 40th anniversary, we received a generous gift from a friend in the industry: Eppendorf. That gift was an exchange program. The teenage child of any Promega employee was given the opportunity to visit an Eppendorf family in another country, and in return host the Eppendorf family’s child in their home. The goal was for both children to experience another culture and build a relationship with each other.
In 2019, 11 Promega children bid good-bye to their parents,
hopped on a plane, and flew to Germany. There they would stay for three weeks with
a family they’ve never met. For all involved, it proved to be a valuable and
positive learning opportunity. Here are a few takeaways from their experience:
Understanding the expression, function and dynamics of
proteins in their native environment is a fundamental goal that’s common to
diverse aspects of molecular and cell biology. To study a protein, it must
first be labeled—either directly or indirectly—with a “tag” that allows
specific and sensitive detection.
Using a labeled antibody to the protein of interest is a
common method to study native proteins. However, antibody-based assays, such as
ELISAs and Western blots, are not suitable for use in live cells. These
techniques are also limited by throughput and sensitivity. Further, suitable
antibodies may not be available for the target protein of interest.
This summer, I had the opportunity to go to the Marine
Biological Laboratory (MBL) in Woods Hole, Massachusetts. MBL was founded in
1888 as an institution that focuses on research and education. Woods Hole is
located on Cape Cod and has rich biodiversity that is the focus of the resident
researchers and the many others that travel there each summer. It was here that
new model organisms were discovered, allowing significant advancement in
various fields. For example, squid have large axons that allowed researchers to
expand our knowledge of neurons.
Over 500 scientists from over 300 institutions in over 30
countries come to MBL each year as trainees1. There are 19 advanced
research training courses for pre-and post-doctoral scientists in development, reproduction,
cell physiology, microbiology, infectious disease, neuroscience, and microscopy.
Faculty that teach the courses are leaders in their respective fields. In
addition, MBL has a neuro-physiology fellowship program through the Grass
Foundation that allows early-stage researchers to come to MBL for 14 weeks to
There are as many different
cancers as there are people with cancer. Unlike infectious diseases, which are
caused by pathogens that are foreign to our bodies (bacteria, viruses, parasites),
cancer cells arise from our body—our own cells gone rogue. Because cancer is a
dysfunction of a person’s normal cells, every cancer reflects the genetic
differences that mark us as individuals. Add to that environmental influences like
diet, tobacco use, the microbiome and even occupation, and the likelihood of
finding a “single” pharmaceutical cure for cancer becomes virtually impossible.
But, while looking for a single cure for all cancers may not be a fruitful activity, defining a best practice for understanding the genetic and protein biomarkers of individual tumors is proving worthwhile.
With another major Star Wars film about to hit the theaters this year, sci-fi enthusiasts are abuzz with excitement to watch epic lightsaber battles and hyperspace travel. But are these sci-fi concepts more grounded in science or fiction? That is what science communicator Kyle Hill aims to explore.
A Wisconsin native, Hill graduated from Marquette University with degrees in engineering and science communication. Now he resides in Los Angeles, where he built a career writing and talking about the intersection of science and pop culture through his video series, Because Science.
This past weekend at the Wisconsin Science Festival, hundreds of fans gathered to hear Hill share his ideas on how the sci-fi concepts in the Star Wars movies aren’t that far off from actual science.